G. Tolis

4.5k total citations
137 papers, 3.4k citations indexed

About

G. Tolis is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, G. Tolis has authored 137 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Molecular Biology and 23 papers in Reproductive Medicine. Recurrent topics in G. Tolis's work include Pituitary Gland Disorders and Treatments (29 papers), Growth Hormone and Insulin-like Growth Factors (28 papers) and Ovarian function and disorders (19 papers). G. Tolis is often cited by papers focused on Pituitary Gland Disorders and Treatments (29 papers), Growth Hormone and Insulin-like Growth Factors (28 papers) and Ovarian function and disorders (19 papers). G. Tolis collaborates with scholars based in Greece, Canada and United States. G. Tolis's co-authors include Henry G. Friesen, H. Guyda, Joseph B. Martin, Adi Mehta, Samarthji Lal, Nicholas Angelopoulos, Andrew V. Schally, Gregory M. Brown, A. M. Comaru-Schally and George P. Chrousos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

G. Tolis

133 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Tolis Greece 31 1.6k 596 487 419 417 137 3.4k
P. W. C. Kloppenborg Netherlands 35 1.8k 1.1× 376 0.6× 444 0.9× 337 0.8× 842 2.0× 141 4.1k
IONE A. KOURIDES United States 37 2.7k 1.7× 637 1.1× 824 1.7× 420 1.0× 500 1.2× 78 4.1k
A. G. H. Smals Netherlands 38 2.3k 1.5× 458 0.8× 685 1.4× 301 0.7× 672 1.6× 156 4.1k
Antonio Bellastella Italy 42 2.9k 1.9× 486 0.8× 765 1.6× 381 0.9× 599 1.4× 160 4.9k
John F. Crigler United States 29 1.2k 0.8× 676 1.1× 1.1k 2.3× 228 0.5× 406 1.0× 82 3.0k
B. L. Pimstone South Africa 33 1.3k 0.8× 191 0.3× 619 1.3× 114 0.3× 576 1.4× 104 3.1k
M. F. Scanlon United Kingdom 36 4.1k 2.6× 307 0.5× 760 1.6× 385 0.9× 1.4k 3.4× 160 5.6k
C. W. BURKE United Kingdom 33 2.2k 1.4× 254 0.4× 319 0.7× 218 0.5× 670 1.6× 73 3.0k
P. Beck‐Peccoz Italy 45 3.7k 2.3× 441 0.7× 1.2k 2.4× 210 0.5× 902 2.2× 182 5.4k
Paolo Comeglio Italy 32 1.0k 0.7× 264 0.4× 442 0.9× 536 1.3× 263 0.6× 96 2.8k

Countries citing papers authored by G. Tolis

Since Specialization
Citations

This map shows the geographic impact of G. Tolis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Tolis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Tolis more than expected).

Fields of papers citing papers by G. Tolis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Tolis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Tolis. The network helps show where G. Tolis may publish in the future.

Co-authorship network of co-authors of G. Tolis

This figure shows the co-authorship network connecting the top 25 collaborators of G. Tolis. A scholar is included among the top collaborators of G. Tolis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Tolis. G. Tolis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xekouki, Paraskevi, Karel Pacák, Madson Q. Almeida, et al.. (2011). Succinate Dehydrogenase (SDH) D Subunit (SDHD) Inactivation in a Growth-Hormone-Producing Pituitary Tumor: A New Association for SDH?. The Journal of Clinical Endocrinology & Metabolism. 97(3). E357–E366. 113 indexed citations
2.
Lytras, Aristides & G. Tolis. (2009). Reproductive disturbances in multiple neuroendocrine tumor syndromes. Endocrine Related Cancer. 16(4). 1125–1138. 6 indexed citations
3.
Κousta, Eleni, Charalambos Hadjiathanasiou, G. Tolis, & Αθανάσιος Παπαθανασίου. (2009). Pleiotropic Genetic Syndromes with Developmental Abnormalities Associated with Obesity. Journal of Pediatric Endocrinology and Metabolism. 22(7). 581–92. 9 indexed citations
4.
Angelopoulos, Nicholas, et al.. (2007). MARKERS OF BONE METABOLISM IN EUGONADAL FEMALE PATIENTS WITH β-THALASSEMIA MAJOR. Pediatric Hematology and Oncology. 24(7). 481–491. 11 indexed citations
5.
Angelopoulos, Nicholas, et al.. (2006). Evaluation of Bone Mineral Density of the Lumbar Spine in Patients With β-Thalassemia Major With Dual-Energy X-Ray Absorptiometry and Quantitative Computed Tomography. Journal of Pediatric Hematology/Oncology. 28(2). 73–78. 20 indexed citations
6.
Κousta, Eleni, G. Tolis, & Stephen Franks. (2005). Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences. HORMONES. 4(3). 133–147. 29 indexed citations
7.
Angelopoulos, Nicholas, Anastasia Goula, & G. Tolis. (2005). Current knowledge in the neurophysiologic modulation of obesity. Metabolism. 54(9). 1202–1217. 15 indexed citations
8.
Krassas, G. E., et al.. (1997). Lanreotide in the treatment of patients with thyroid eye disease. European Journal of Endocrinology. 136(4). 416–422. 53 indexed citations
9.
Markussis, Viron, et al.. (1994). Octreotide Effect on Ovarian Morphology in Insulin‐Resistant PCOS Patients Following Six‐Month Decapeptyl Treatment. American Journal of Reproductive Immunology. 31(2-3). 104–111. 4 indexed citations
10.
Markussis, Viron, et al.. (1994). The role of insulin in ovarian size in patients with the polycystic ovary syndrome. Gynecological Endocrinology. 8(3). 197–202. 8 indexed citations
11.
Lüdecke, Dieter K., et al.. (1990). ACTH, Cushing's syndrome, and other hypercortisolemic states. Raven Press eBooks. 26 indexed citations
12.
Dacou‐Voutetakis, Catherine, et al.. (1985). 186 TREATMENT OF PRECOCIOUS PUBERTY (PP) WITH A MONTHLY INJECTION OF D-Trp6 LHRH ANALOG (A). Pediatric Research. 19(6). 634–634. 1 indexed citations
14.
Wallach, Edward E., Víctor Ruiz-Velasco, & G. Tolis. (1984). Pregnancy in hyperprolactinemic women. Fertility and Sterility. 41(6). 793–805. 41 indexed citations
16.
S, Lal, G. Tolis, Timothy J. McDonald, Pablo Cervantes, & John Dupré. (1981). Effect of Clonidine on Growth Hormone and Glucagon Secretion. Hormone and Metabolic Research. 13(11). 648–649. 11 indexed citations
17.
Martin, Joseph B., et al.. (1979). Failure of naloxone to influence physiological growth hormone and prolactin secretion. Brain Research. 168(1). 210–215. 51 indexed citations
18.
Küchel, O, et al.. (1976). Effects of beta-adrenergic blockade on plasma cyclic AMP and blood sugar responses to glucagon and isoproterenol in man.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(3). 189–94. 1 indexed citations
19.
Martin, Joseph B., Samarthji Lal, G. Tolis, & Henry G. Friesen. (1974). Inhibition by Apomorphine of Prolactin Secretion in Patients with Elevated Serum Prolactin. The Journal of Clinical Endocrinology & Metabolism. 39(1). 180–182. 58 indexed citations
20.
Pozo, E. del, L. Varga, H.J. Wyss, et al.. (1974). Clinical and Hormonal Response To Bromocriptin (CB-154) in the Galactorrhea Syndromes. The Journal of Clinical Endocrinology & Metabolism. 39(1). 18–26. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026